
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic […]